logo
logo

LifeSprout, Inc. Closes $28.5 Million Series A Financing

LifeSprout, Inc. Closes $28.5 Million Series A Financing

04/27/20, 12:43 PM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/US.svgbaltimore
Money raised
$28 million
Round Type
series a
 LifeSprout, a privately-held regenerative medicine company founded with technology licensed from Johns Hopkins University, has closed a $28.5 million Series A financing. The company is using proceeds to support clinical development of novel therapeutic products from its Regenerative Matrix platform.

Company Info

Company
Life Sprout
Location
baltimore, maryland, united states
Additional Info
LifeSprout, Inc. is a privately held company developing revolutionary products for aesthetic and regenerative medicine. The company's Regenerative Matrix platform leverages advances in materials science to create products that look and feel like the body's own tissues. LifeSprout is turning this technology into a suite of products for the millions of patients with tissue losses from aging, cancer, metabolic disease, and orphan indications. The company's lead product Lumina™ is a breakthrough family of aesthetic fillers enabling immediate, natural restoration with biostimulatory effects. LifeSprout's next generation cell therapy products use the power of the platform to promote true tissue regeneration. To learn more visit https://www.lifesproutbio.com/.    

Related People